Published in Brain on March 01, 2012
Quantitative application of the primary progressive aphasia consensus criteria. Neurology (2014) 1.64
Logopenic and nonfluent variants of primary progressive aphasia are differentiated by acoustic measures of speech production. PLoS One (2014) 1.57
The non-fluent/agrammatic variant of primary progressive aphasia. Lancet Neurol (2012) 1.33
Syndromes dominated by apraxia of speech show distinct characteristics from agrammatic PPA. Neurology (2013) 1.19
Distinct regional anatomic and functional correlates of neurodegenerative apraxia of speech and aphasia: an MRI and FDG-PET study. Brain Lang (2013) 1.09
Disruption of large-scale neural networks in non-fluent/agrammatic variant primary progressive aphasia associated with frontotemporal degeneration pathology. Brain Lang (2012) 1.01
The evolution of primary progressive apraxia of speech. Brain (2014) 0.99
FDG PET and MRI in logopenic primary progressive aphasia versus dementia of the Alzheimer's type. PLoS One (2013) 0.96
Cognitive and behavioral features of c9FTD/ALS. Alzheimers Res Ther (2012) 0.96
[18F]AV-1451 tau-PET uptake does correlate with quantitatively measured 4R-tau burden in autopsy-confirmed corticobasal degeneration. Acta Neuropathol (2016) 0.95
Elevated occipital β-amyloid deposition is associated with widespread cognitive impairment in logopenic progressive aphasia. J Neurol Neurosurg Psychiatry (2013) 0.94
Frontal white matter tracts sustaining speech production in primary progressive aphasia. J Neurosci (2014) 0.90
The diagnosis and understanding of apraxia of speech: why including neurodegenerative etiologies may be important. J Speech Lang Hear Res (2012) 0.90
The Apraxia of Speech Rating Scale: a tool for diagnosis and description of apraxia of speech. J Commun Disord (2014) 0.89
Assessing the clinical effect of residual cortical disconnection after ischemic strokes. Stroke (2014) 0.87
Abnormal brain metabolism on FDG-PET/CT is a common early finding in autoimmune encephalitis. Neurol Neuroimmunol Neuroinflamm (2017) 0.86
Clinical, FDG and amyloid PET imaging in posterior cortical atrophy. J Neurol (2015) 0.86
Treatment for apraxia of speech in nonfluent variant primary progressive aphasia. Behav Neurol (2013) 0.85
Working memory and language network dysfunctions in logopenic aphasia: a task-free fMRI comparison with Alzheimer's dementia. Neurobiol Aging (2014) 0.85
Neuroimaging comparison of primary progressive apraxia of speech and progressive supranuclear palsy. Eur J Neurol (2012) 0.84
A novel tau mutation, p.K317N, causes globular glial tauopathy. Acta Neuropathol (2015) 0.84
Dominant frontotemporal dementia mutations in 140 cases of primary progressive aphasia and speech apraxia. Dement Geriatr Cogn Disord (2015) 0.84
Nonverbal oral apraxia in primary progressive aphasia and apraxia of speech. Neurology (2014) 0.83
Primary progressive apraxia of speech: clinical features and acoustic and neurologic correlates. Am J Speech Lang Pathol (2015) 0.83
Ideomotor apraxia in agrammatic and logopenic variants of primary progressive aphasia. J Neurol (2013) 0.82
Progranulin-associated PiB-negative logopenic primary progressive aphasia. J Neurol (2014) 0.82
Core auditory processing deficits in primary progressive aphasia. Brain (2016) 0.82
Clinical and neuroimaging biomarkers of amyloid-negative logopenic primary progressive aphasia. Brain Lang (2015) 0.81
APOE ε4 influences β-amyloid deposition in primary progressive aphasia and speech apraxia. Alzheimers Dement (2014) 0.81
Primary progressive aphasia: A dementia of the language network. Dement Neuropsychol (2013) 0.81
Motor Speech Disorders Associated with Primary Progressive Aphasia. Aphasiology (2014) 0.81
Classification and clinicoradiologic features of primary progressive aphasia (PPA) and apraxia of speech. Cortex (2015) 0.80
Structural asymmetry of anterior insula: behavioral correlates and individual differences. Brain Lang (2013) 0.80
Aphasia with left occipitotemporal hypometabolism: a novel presentation of posterior cortical atrophy? J Clin Neurosci (2013) 0.80
Clinical diagnostic criteria and classification controversies in frontotemporal lobar degeneration. Int Rev Psychiatry (2013) 0.79
Features of Patients With Nonfluent/Agrammatic Primary Progressive Aphasia With Underlying Progressive Supranuclear Palsy Pathology or Corticobasal Degeneration. JAMA Neurol (2016) 0.78
Recent advances in the imaging of frontotemporal dementia. Curr Neurol Neurosci Rep (2012) 0.78
Key emerging issues in progressive supranuclear palsy and corticobasal degeneration. J Neurol (2015) 0.78
Patterns of poststroke brain damage that predict speech production errors in apraxia of speech and aphasia dissociate. Stroke (2015) 0.78
Neuroanatomical foundations of naming impairments across different neurologic conditions. Neurology (2015) 0.78
Frontotemporal Dementias. Continuum (Minneap Minn) (2016) 0.77
Behavioral, computational, and neuroimaging studies of acquired apraxia of speech. Front Hum Neurosci (2014) 0.77
Clinical course of primary progressive aphasia: clinical and FDG-PET patterns. J Neurol (2014) 0.77
Aphasic variant of Alzheimer disease: Clinical, anatomic, and genetic features. Neurology (2016) 0.77
Radiological biomarkers for diagnosis in PSP: Where are we and where do we need to be? Mov Disord (2017) 0.77
Classification of the primary progressive aphasias: principles and review of progress since 2011. Alzheimers Res Ther (2016) 0.76
Primary progressive aphasia and apraxia of speech. Semin Neurol (2013) 0.76
Motor Speech Apraxia in a 70-Year-Old Man with Left Dorsolateral Frontal Arachnoid Cyst: A [(18)F]FDG PET-CT Study. Case Rep Neurol Med (2016) 0.75
Neuropsychiatric symptoms in primary progressive aphasia and apraxia of speech. Dement Geriatr Cogn Disord (2015) 0.75
Occupational differences between Alzheimer's and aphasic dementias: implication for teachers. Am J Alzheimers Dis Other Demen (2013) 0.75
Fluorodeoxyglucose F18 PET in progressive emotional dysprosody. Neurology (2012) 0.75
Clinical and MRI models predicting amyloid deposition in progressive aphasia and apraxia of speech. Neuroimage Clin (2016) 0.75
The Role of Single-Subject Brain Metabolic Patterns in the Early Differential Diagnosis of Primary Progressive Aphasias and in Prediction of Progression to Dementia. J Alzheimers Dis (2016) 0.75
Sample size calculations for clinical trials targeting tauopathies: a new potential disease target. J Neurol (2015) 0.75
Tracking the development of agrammatic aphasia: A tensor-based morphometry study. Cortex (2016) 0.75
Neurocognitive speed associates with frontotemporal lobar degeneration TDP-43 subtypes. J Clin Neurosci (2013) 0.75
Temporal acoustic measures distinguish primary progressive apraxia of speech from primary progressive aphasia. Brain Lang (2017) 0.75
Activity associated with speech articulation measured through direct cortical recordings. Brain Lang (2017) 0.75
Current Understanding of Neurodegenerative Diseases Associated With the Protein Tau. Mayo Clin Proc (2017) 0.75
"Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res (1975) 301.74
Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology (1984) 119.59
Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain. Neuroimage (2002) 49.90
Advances in functional and structural MR image analysis and implementation as FSL. Neuroimage (2004) 49.54
Voxel-based morphometry--the methods. Neuroimage (2000) 34.79
Unified segmentation. Neuroimage (2005) 30.20
The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc (2005) 27.90
Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology (1998) 26.77
Tract-based spatial statistics: voxelwise analysis of multi-subject diffusion data. Neuroimage (2006) 23.57
A nonparametric method for automatic correction of intensity nonuniformity in MRI data. IEEE Trans Med Imaging (1998) 23.54
A new clinical scale for the staging of dementia. Br J Psychiatry (1982) 21.77
Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology (2005) 21.67
El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord (2000) 15.38
Characterization and propagation of uncertainty in diffusion-weighted MR imaging. Magn Reson Med (2003) 12.09
Classification of primary progressive aphasia and its variants. Neurology (2011) 11.82
Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov Disord (2008) 9.52
The FAB: a Frontal Assessment Battery at bedside. Neurology (2000) 8.93
Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop. Neurology (1996) 8.82
Reliability in multi-site structural MRI studies: effects of gradient non-linearity correction on phantom and human data. Neuroimage (2005) 8.50
Second consensus statement on the diagnosis of multiple system atrophy. Neurology (2008) 7.27
Cognition and anatomy in three variants of primary progressive aphasia. Ann Neurol (2004) 7.07
Validation of the NPI-Q, a brief clinical form of the Neuropsychiatric Inventory. J Neuropsychiatry Clin Neurosci (2000) 6.54
The prevalence of frontotemporal dementia. Neurology (2002) 5.73
Slowly progressive aphasia without generalized dementia. Ann Neurol (1982) 5.66
A diagnostic approach in Alzheimer's disease using three-dimensional stereotactic surface projections of fluorine-18-FDG PET. J Nucl Med (1995) 4.44
A new brain region for coordinating speech articulation. Nature (1996) 4.33
Preliminary NINDS neuropathologic criteria for Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy). Neurology (1994) 4.24
Abeta amyloid and glucose metabolism in three variants of primary progressive aphasia. Ann Neurol (2008) 4.15
The token test: A sensitive test to detect receptive disturbances in aphasics. Brain (1962) 4.12
Clinicopathological and imaging correlates of progressive aphasia and apraxia of speech. Brain (2006) 4.07
Primary progressive aphasia. Ann Neurol (2001) 3.72
The selective impairment of semantic memory. Q J Exp Psychol (1975) 3.63
Clinicopathologic analysis of frontotemporal and corticobasal degenerations and PSP. Neurology (2006) 3.60
Conversion of amyloid positive and negative MCI to AD over 3 years: an 11C-PIB PET study. Neurology (2009) 3.49
Corticobasal degeneration and its relationship to progressive supranuclear palsy and frontotemporal dementia. Ann Neurol (2003) 3.22
Primary progressive aphasia--a language-based dementia. N Engl J Med (2003) 3.14
What's in a name: voxel-based morphometric analyses of MRI and naming difficulty in Alzheimer's disease, frontotemporal dementia and corticobasal degeneration. Brain (2004) 2.90
Progranulin mutations in primary progressive aphasia: the PPA1 and PPA3 families. Arch Neurol (2007) 2.68
Comparative evaluation of MR-based partial-volume correction schemes for PET. J Nucl Med (1999) 2.30
Frontal behavioral inventory: diagnostic criteria for frontal lobe dementia. Can J Neurol Sci (1997) 2.23
Does corticobasal degeneration exist? A clinicopathological re-evaluation. Brain (2010) 2.19
Distinct anatomical subtypes of the behavioural variant of frontotemporal dementia: a cluster analysis study. Brain (2009) 1.93
Clinicopathological correlations in corticobasal degeneration. Ann Neurol (2011) 1.86
Development of methodology for conducting clinical trials in frontotemporal lobar degeneration. Brain (2008) 1.82
Knowledge of famous faces and names in semantic dementia. Brain (2004) 1.68
Action (verb) fluency: test-retest reliability, normative standards, and construct validity. J Int Neuropsychol Soc (2005) 1.65
In vivo amyloid imaging in autopsy-confirmed Parkinson disease with dementia. Neurology (2010) 1.58
Prediction of pathology in primary progressive language and speech disorders. Neurology (2009) 1.57
Gray and white matter water diffusion in the syndromic variants of frontotemporal dementia. Neurology (2010) 1.57
Apraxia of speech and nonfluent aphasia: a new clinical marker for corticobasal degeneration and progressive supranuclear palsy. Curr Opin Neurol (2008) 1.56
The northwestern anagram test: measuring sentence production in primary progressive aphasia. Am J Alzheimers Dis Other Demen (2009) 1.55
Primary progressive aphasia--differentiation from Alzheimer's disease. Ann Neurol (1987) 1.44
The neuropathology and clinical phenotype of FTD with progranulin mutations. Acta Neuropathol (2007) 1.43
Atypical progressive supranuclear palsy underlying progressive apraxia of speech and nonfluent aphasia. Neurocase (2005) 1.41
COWAT metanorms across age, education, and gender. Appl Neuropsychol (2001) 1.39
An empirically derived short form of the Boston naming test. Arch Clin Neuropsychol (1999) 1.24
The anatomic correlate of prosopagnosia in semantic dementia. Neurology (2008) 1.18
Slowly progressive anarthria with late anterior opercular syndrome: a variant form of frontal cortical atrophy syndromes. J Neurol Sci (1996) 1.14
Making sense of progressive non-fluent aphasia: an analysis of conversational speech. Brain (2009) 1.14
Unusual clinical presentations of cortical-basal ganglionic degeneration. Ann Neurol (1996) 1.13
Syndromes of nonfluent primary progressive aphasia: a clinical and neurolinguistic analysis. Neurology (2010) 1.11
Realizing the potential of positron emission tomography with 18F-fluorodeoxyglucose to improve the treatment of Alzheimer's disease. Alzheimers Dement (2007) 1.10
Aphasia and non-verbal disorders of language. Brain (1962) 1.09
Disrupted thalamocortical connectivity in PSP: a resting-state fMRI, DTI, and VBM study. Parkinsonism Relat Disord (2011) 1.08
Clinical correlates of white matter tract degeneration in progressive supranuclear palsy. Arch Neurol (2011) 1.05
Pure progressive aphemia. J Neurol Neurosurg Psychiatry (1993) 0.98
Brain activation patterns during a verbal fluency test-a functional MRI study in healthy volunteers and patients with schizophrenia. Schizophr Res (2004) 0.90
Imaging in primary progressive aphasia. Neuroradiology (1997) 0.89
Can the frontal assessment battery (FAB) differentiate bradykinetic rigid syndromes? Relation of the FAB to formal neuropsychological testing. Neurocase (2005) 0.87
A case of progressive apraxia of speech in pathologically verified Alzheimer disease. Cogn Behav Neurol (2007) 0.86
Progressive apraxia of speech presenting as isolated disorder of speech articulation and prosody: a case report. Neurocase (2008) 0.83
On the role of quantitative brain imaging in the differential diagnosis of speech disorders. Psychiatry Clin Neurosci (2002) 0.83
The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement (2011) 24.26
Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement (2011) 24.02
11C PiB and structural MRI provide complementary information in imaging of Alzheimer's disease and amnestic mild cognitive impairment. Brain (2008) 9.64
Ways toward an early diagnosis in Alzheimer's disease: the Alzheimer's Disease Neuroimaging Initiative (ADNI). Alzheimers Dement (2005) 7.90
Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: implications for sequence of pathological events in Alzheimer's disease. Brain (2009) 7.20
Automatic classification of MR scans in Alzheimer's disease. Brain (2008) 6.71
Protective variant for hippocampal atrophy identified by whole exome sequencing. Ann Neurol (2015) 5.10
Mild cognitive impairment: ten years later. Arch Neurol (2009) 5.02
Recommendations on the use of 18F-FDG PET in oncology. J Nucl Med (2008) 4.71
Mild cognitive impairment can be distinguished from Alzheimer disease and normal aging for clinical trials. Arch Neurol (2004) 4.66
The clinical use of structural MRI in Alzheimer disease. Nat Rev Neurol (2010) 4.59
Alzheimer's disease diagnosis in individual subjects using structural MR images: validation studies. Neuroimage (2007) 4.41
Brain beta-amyloid measures and magnetic resonance imaging atrophy both predict time-to-progression from mild cognitive impairment to Alzheimer's disease. Brain (2010) 4.39
An operational approach to National Institute on Aging-Alzheimer's Association criteria for preclinical Alzheimer disease. Ann Neurol (2012) 4.36
The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inception. Alzheimers Dement (2011) 4.25
Clinicopathological and imaging correlates of progressive aphasia and apraxia of speech. Brain (2006) 4.07
Longitudinal stability of MRI for mapping brain change using tensor-based morphometry. Neuroimage (2006) 3.85
The Alzheimer's disease neuroimaging initiative: progress report and future plans. Alzheimers Dement (2010) 3.85
Identification of common variants associated with human hippocampal and intracranial volumes. Nat Genet (2012) 3.73
Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease: a randomized trial. JAMA (2010) 3.58
Testing the right target and right drug at the right stage. Sci Transl Med (2011) 3.55
3D maps from multiple MRI illustrate changing atrophy patterns as subjects progress from mild cognitive impairment to Alzheimer's disease. Brain (2007) 3.53
A longitudinal study of brain volume changes in normal aging using serial registered magnetic resonance imaging. Arch Neurol (2003) 3.44
Tensor-based morphometry as a neuroimaging biomarker for Alzheimer's disease: an MRI study of 676 AD, MCI, and normal subjects. Neuroimage (2008) 3.40
Whole genome association study of brain-wide imaging phenotypes for identifying quantitative trait loci in MCI and AD: A study of the ADNI cohort. Neuroimage (2010) 3.27
Clinical Core of the Alzheimer's Disease Neuroimaging Initiative: progress and plans. Alzheimers Dement (2010) 3.11
Neuroimaging signatures of frontotemporal dementia genetics: C9ORF72, tau, progranulin and sporadics. Brain (2012) 3.08
Comparison of different methodological implementations of voxel-based morphometry in neurodegenerative disease. Neuroimage (2005) 3.06
Amyloid-related imaging abnormalities in amyloid-modifying therapeutic trials: recommendations from the Alzheimer's Association Research Roundtable Workgroup. Alzheimers Dement (2011) 3.05
Alzheimer's Disease Neuroimaging Initiative biomarkers as quantitative phenotypes: Genetics core aims, progress, and plans. Alzheimers Dement (2010) 2.79
Update on the biomarker core of the Alzheimer's Disease Neuroimaging Initiative subjects. Alzheimers Dement (2010) 2.68
Magnetic resonance elastography of the brain. Neuroimage (2007) 2.59
Focal atrophy in dementia with Lewy bodies on MRI: a distinct pattern from Alzheimer's disease. Brain (2007) 2.58
Brain β-amyloid load approaches a plateau. Neurology (2013) 2.50
Assessing the temporal relationship between cognition and gait: slow gait predicts cognitive decline in the Mayo Clinic Study of Aging. J Gerontol A Biol Sci Med Sci (2012) 2.48
Neuroimaging in Alzheimer disease: an evidence-based review. Neuroimaging Clin N Am (2003) 2.43
Characterization of frontotemporal dementia and/or amyotrophic lateral sclerosis associated with the GGGGCC repeat expansion in C9ORF72. Brain (2012) 2.43
Automatic quality assessment in structural brain magnetic resonance imaging. Magn Reson Med (2009) 2.43
3D characterization of brain atrophy in Alzheimer's disease and mild cognitive impairment using tensor-based morphometry. Neuroimage (2008) 2.40
Effect of APOE ε4 status on intrinsic network connectivity in cognitively normal elderly subjects. Arch Neurol (2011) 2.40
Association of ambulatory blood pressure with ischemic brain injury. Hypertension (2007) 2.39
Predicting clinical scores from magnetic resonance scans in Alzheimer's disease. Neuroimage (2010) 2.33
The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inception. Alzheimers Dement (2013) 2.32
Validation of a fully automated 3D hippocampal segmentation method using subjects with Alzheimer's disease mild cognitive impairment, and elderly controls. Neuroimage (2008) 2.30
Optimizing power to track brain degeneration in Alzheimer's disease and mild cognitive impairment with tensor-based morphometry: an ADNI study of 515 subjects. Neuroimage (2009) 2.28
Automated 3D mapping of hippocampal atrophy and its clinical correlates in 400 subjects with Alzheimer's disease, mild cognitive impairment, and elderly controls. Hum Brain Mapp (2009) 2.28
Prediction of conversion from mild cognitive impairment to Alzheimer's disease dementia based upon biomarkers and neuropsychological test performance. Neurobiol Aging (2010) 2.27
Automated mapping of hippocampal atrophy in 1-year repeat MRI data from 490 subjects with Alzheimer's disease, mild cognitive impairment, and elderly controls. Neuroimage (2008) 2.25
Effect of apolipoprotein E on biomarkers of amyloid load and neuronal pathology in Alzheimer disease. Ann Neurol (2010) 2.16
Methodological considerations for measuring rates of brain atrophy. J Magn Reson Imaging (2003) 2.16
Boosting power for clinical trials using classifiers based on multiple biomarkers. Neurobiol Aging (2010) 2.13
A commonly carried allele of the obesity-related FTO gene is associated with reduced brain volume in the healthy elderly. Proc Natl Acad Sci U S A (2010) 2.12
Neuroimaging correlates of pathologically defined subtypes of Alzheimer's disease: a case-control study. Lancet Neurol (2012) 2.09
Longitudinal MRI atrophy biomarkers: relationship to conversion in the ADNI cohort. Neurobiol Aging (2010) 2.05
Alzheimer's disease neuroimaging initiative: a one-year follow up study using tensor-based morphometry correlating degenerative rates, biomarkers and cognition. Neuroimage (2009) 2.03
Brain injury biomarkers are not dependent on β-amyloid in normal elderly. Ann Neurol (2013) 2.03
Change in rates of cerebral atrophy over time in early-onset Alzheimer's disease: longitudinal MRI study. Lancet (2003) 2.02
Patterns of atrophy in pathologically confirmed FTLD with and without motor neuron degeneration. Neurology (2006) 2.01
Indicators of amyloid burden in a population-based study of cognitively normal elderly. Neurology (2012) 2.01
Prominent phenotypic variability associated with mutations in Progranulin. Neurobiol Aging (2007) 2.00
Antemortem MRI based STructural Abnormality iNDex (STAND)-scores correlate with postmortem Braak neurofibrillary tangle stage. Neuroimage (2008) 1.98
Proton MR spectroscopy in mild cognitive impairment and Alzheimer disease: comparison of 1.5 and 3 T. AJNR Am J Neuroradiol (2003) 1.96
A comparison of the diagnostic accuracy of 18F-FDG PET and CT in the characterization of solitary pulmonary nodules. J Nucl Med (2008) 1.95
Longitudinal changes in white matter disease and cognition in the first year of the Alzheimer disease neuroimaging initiative. Arch Neurol (2010) 1.94
Genome-wide analysis reveals novel genes influencing temporal lobe structure with relevance to neurodegeneration in Alzheimer's disease. Neuroimage (2010) 1.94
Distinct anatomical subtypes of the behavioural variant of frontotemporal dementia: a cluster analysis study. Brain (2009) 1.93
Beta-amyloid burden is not associated with rates of brain atrophy. Ann Neurol (2008) 1.93
Intensity non-uniformity correction using N3 on 3-T scanners with multichannel phased array coils. Neuroimage (2007) 1.93
Voxel-based morphometry in autopsy proven PSP and CBD. Neurobiol Aging (2006) 1.92
Sex, apolipoprotein E epsilon 4 status, and hippocampal volume in mild cognitive impairment. Arch Neurol (2005) 1.91
Rates of cerebral atrophy differ in different degenerative pathologies. Brain (2007) 1.90
The ENIGMA Consortium: large-scale collaborative analyses of neuroimaging and genetic data. Brain Imaging Behav (2014) 1.90
Non-stationarity in the "resting brain's" modular architecture. PLoS One (2012) 1.90
Comparison of 18F-FDG and PiB PET in cognitive impairment. J Nucl Med (2009) 1.90
Measurement of MRI scanner performance with the ADNI phantom. Med Phys (2009) 1.85
Patterns of atrophy differ among specific subtypes of mild cognitive impairment. Arch Neurol (2007) 1.84
Spherical navigator echoes for full 3D rigid body motion measurement in MRI. Magn Reson Med (2002) 1.83